Markets

Catasys, a micro-cap substance abuse outpatient program provider, files for a $15 million Nasdaq uplisting

A generic image of multiple stacks of coins
Credit: Shutterstock photo

Catasys, which provides substance abuse, depression and anxiety outpatient programs, filed on Friday with the SEC to raise up to $15 million in an initial public offering. Shares of the company are listed on the OTCQB Marketplace and finished Friday at $1.30.

The Los Angeles, CA-based company was founded in 2003 and booked $5 million in sales for the 12 months ended September 30, 2016. It plans to list on the Nasdaq under the symbol CATS. on the deal. No pricing terms were disclosed.

The article Catasys, a micro-cap substance abuse outpatient program provider, files for a $15 million Nasdaq uplisting originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

OTRK

Other Topics

IPOs

Latest Markets Videos